| | 159351-69-6 Basic information More.. |
| Product Name: | Everolimus | | Synonyms: | Everolimus（mixture of isomers）;Everolimus powder;CERTICAN; ZORTRESS; AFINITOR;Rapamycin, 42-O-(2-hydroxyethyl)-;Everolimus;Certican;CERTICAN(R);EveroliMus(RAD-001) | | CAS: | 159351-69-6 | | MF: | C53H83NO14 | | MW: | 958.22 | | EINECS: | 621-003-9 | | Mol File: | 159351-69-6.mol |  |
Use
Everolimus is a derivative of Rapamycin(sirolimus), and works similarly to Rapamycin as an mTOR(mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mTOR inhibitors, Everolimus takes effect solely on the mTORC1 protein and not on the mTORC2 protein[1]. In transplantation medicine, it is marketed under the trade names Zortress(USA) and Certican(Europe). It has been also used for the treatment of tumors, being marketed as Afinitor(general tumours) and Votubia(tumours as a result of TSC) in oncology.
- Everolimus
-
- 2025-11-30
- CAS:159351-69-6
- Min. Order:
- Purity: 0.99
- Supply Ability:
- Everolimus
-
- US $0.00-0.00 / g
- 2025-11-29
- CAS:159351-69-6
- Min. Order: 1g
- Purity: 95.0%～102.0%
- Supply Ability: 1kg/month
- Everolimus
-
- US $5.00-0.50 / KG
- 2025-11-28
- CAS:159351-69-6
- Min. Order: 1KG
- Purity: 99% hplc
- Supply Ability: 500TONS
|
|
159351-69-6
Recommend Suppliers |
|